-
- Feb 09 2016
-
PDS Biotechnology Signs Agreement with National Cancer Institute
- Standard
- breast cancer, cancer immunotherapies, CRADA, HPV-related cancers, Jay Berzofsky, Lauren Wood, Masaki Terabe, National Cancer Institute, NCI, PDS Biotechnology, press release, prostate cancer, US National Institutes of Health, versamune
PDS Biotechnology Signs Agreement with National Cancer Institute to Form Phase II Clinical Collaboration for Novel Cancer Immunotherapies Based on PDS’s Versamune® Platform Technology.
Read more